International multicentre retrospective analysis of thiotepa-based autologous stem cell transplantation for secondary central nervous system lymphoma
Name:
36300776.pdf
Size:
1.047Mb
Format:
PDF
Description:
Identified with Open Access button
Authors
Khwaja, J.Kirkwood, A. A.
Isbell, L. K.
Steffanoni, S.
Goradia, H.
Pospiech, L.
Fail, T.
Nicholson, E.
Fletcher, K.
Linton, Kim M
Parsons, K. E.
Elmusharaf, N.
Eccersley, L.
Eyre, T. A.
Chaganti, S.
Smith, J.
Thakrar, N.
Kutilina, A.
Calimeri, T.
Martinez-Calle, N.
El-Sharkawi, D.
Osborne, W.
Illerhaus, G.
Fox, C. P.
Ferreri, A. J.
Schorb, E.
Cwynarski, K.
Affiliation
University College London Hospitals, London, UKIssue Date
2022
Metadata
Show full item recordCitation
Khwaja J, Kirkwood AA, Isbell LK, Steffanoni S, Goradia H, Pospiech L, et al. International multicentre retrospective analysis of thiotepa-based autologous stem cell transplantation for secondary central nervous system lymphoma. Haematologica. 2022 Oct 27. PubMed PMID: 36300776. Epub 2022/10/28. eng.Journal
HaematologicaDOI
10.3324/haematol.2022.281640PubMed ID
36300776Additional Links
https://dx.doi.org/10.3324/haematol.2022.281640Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.3324/haematol.2022.281640
Scopus Count
Collections
Related articles
- Treatment of patients with secondary central nervous system lymphoma with high-dose busulfan/thiotepa-based conditioning and autologous stem cell transplant.
- Authors: Oh DH, Chua N, Street L, Stewart DA
- Issue date: 2016
- High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma: Data From the Japan Society for Hematopoietic Cell Transplantation Registry.
- Authors: Kondo E, Ikeda T, Izutsu K, Chihara D, Shimizu-Koresawa R, Fujii N, Sakai T, Kondo T, Kubo K, Kato Y, Akasaka T, Fukuda T, Ichinohe T, Atsuta Y, Suzumiya J, Suzuki R, Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantation
- Issue date: 2019 May
- High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission.
- Authors: DeFilipp Z, Li S, El-Jawahri A, Armand P, Nayak L, Wang N, Batchelor TT, Chen YB
- Issue date: 2017 Aug 15
- An expanded-access clinical study of thiotepa (DSP-1958) high-dose chemotherapy before autologous hematopoietic stem cell transplantation in patients with malignant lymphoma.
- Authors: Nishikori M, Masaki Y, Fujii N, Ikeda T, Takahara-Matsubara M, Sugimoto S, Kondo E
- Issue date: 2022 Mar
- Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma.
- Authors: Chen YB, Batchelor T, Li S, Hochberg E, Brezina M, Jones S, Del Rio C, Curtis M, Ballen KK, Barnes J, Chi AS, Dietrich J, Driscoll J, Gertsner ER, Hochberg F, LaCasce AS, McAfee SL, Spitzer TR, Nayak L, Armand P
- Issue date: 2015 Jan 15